Attention-deficit hyperactivity disorder cost-effectiveness of therapy: Difference between revisions
No edit summary |
No edit summary |
||
| Line 9: | Line 9: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Psychiatry]] | [[Category:Psychiatry]] | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
Latest revision as of 16:49, 10 November 2016
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Charmaine Patel, M.D. [2], Haleigh Williams, B.S.
|
Attention-deficit hyperactivity disorder Microchapters |
|
Differentiating Attention-Deficit Hyperactivity Disorder from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Template:Attention-deficit hyperactivity disorder On the Web |
|
American Roentgen Ray Society Images of Attention-deficit hyperactivity disorder cost-effectiveness of therapy |
|
FDA on Attention-deficit hyperactivity disorder cost-effectiveness of therapy |
|
CDC on Attention-deficit hyperactivity disorder cost-effectiveness of therapy |
|
Attention-deficit hyperactivity disorder cost-effectiveness of therapy in the news |
|
Blogs on Attention-deficit hyperactivity disorder cost-effectiveness of therapy |
|
Directions to Hospitals Treating Attention-deficit hyperactivity disorder |
Overview
Comorbid disorders or substance abuse can make finding the proper diagnosis and the right overall treatment more costly and time-consuming. Psychosocial therapy is useful in treating some comorbid conditions.[1]